A case of malignant rheumatoid arthritis complicated by secondary amyloidosis and membranous nephropathy

A 30-year-old man had been treated for malignant rheumatoid arthritis from with a nonsteroidal anti-inflammatory drug, then bucillamine for six months and prednisolone. Mild proteinuria appeared in 4 years after bucillamine therapy was conducted. The patient was admitted to our hospital for a renal...

Full description

Saved in:
Bibliographic Details
Published inNihon Jinzo Gakkai shi Vol. 40; no. 8; pp. 607 - 611
Main Authors NAKANISHI, Kazushige, IWAHASHI, Chikara, HANDA, Yuichi, HARA, Noriko, HAMADA, Kaoru, NAGAI, Yohko, KAWAMURA, Sadao, NAKAMURA, Katsuhiko
Format Journal Article
LanguageJapanese
Published Japan Japanese Society of Nephrology 1998
Subjects
Adult
Amyloidosis - etiology
Arthritis, Rheumatoid - complications
Glomerulonephritis, Membranous - etiology
Glomerulonephritis, Membranous - pathology
Hepatitis B - complications
Humans
Kidney - pathology
Male
Proteinuria - etiology
secondary amyloidosis, membranous nephropathy, malignant rheumatoid arthritis, dimethyl sulfoxide
Online AccessGet full text

Cover

More Information
Summary:A 30-year-old man had been treated for malignant rheumatoid arthritis from with a nonsteroidal anti-inflammatory drug, then bucillamine for six months and prednisolone. Mild proteinuria appeared in 4 years after bucillamine therapy was conducted. The patient was admitted to our hospital for a renal biopsy in The specimen revealed secondary amyloidosis and membranous nephropathy (MGN). These findings suggest that MGN unrelated to bucillamine therapy might have occured with secondary amyloidosis in rheumatoid arthritis.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Report-3
ObjectType-Case Study-4
ISSN:0385-2385
1884-0728
DOI:10.14842/jpnjnephrol1959.40.607